BridgeMD
Compares treatment options for Postoperative Pain Management
Official title Intrathecal Morphine Versus Trocar-Site and Intraperitoneal Bupivacaine for Quality of Recovery After Laparoscopic Hysterectomy
ClinicalTrials.gov ID: NCT07232108
What this study is testing
What is Intrathecal Morphine?
Intrathecal Morphine is an investigational medicine, given as an injectable medicine, being studied as a potential treatment for postoperative pain management.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This study aims to compare the effects of intrathecal morphine with trocar-site infiltration and intraperitoneal bupivacaine on postoperative pain control, quality of recovery, and inflammatory response in patients undergoing elective laparoscopic hysterectomy. Laparoscopic hysterectomy is widely used for benign gynecologic conditions, but postoperative pain may result from trocar-site trauma, peritoneal irritation, and carbon dioxide insufflation.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65, women only
You may be able to join if
- Female patients aged 18-65 years.
- Elective laparoscopic hysterectomy planned for benign gynecological conditions.
- American Society of Anesthesiologists (ASA) physical status I-III.
- Ability to provide written informed consent.
You likely can't join if
- Coagulopathy or bleeding disorders.
- Opioid dependence or chronic opioid use.
- Allergy or contraindication to local anesthetics or morphine.
- Contraindication to neuraxial (spinal) anesthesia.
- History of chronic pain syndromes.
- Severe renal or hepatic dysfunction.
See the full eligibility criteria
- Female patients aged 18-65 years.
- Elective laparoscopic hysterectomy planned for benign gynecological conditions.
- American Society of Anesthesiologists (ASA) physical status I-III.
- Ability to provide written informed consent.
- Coagulopathy or bleeding disorders.
- Opioid dependence or chronic opioid use.
- Allergy or contraindication to local anesthetics or morphine.
- Contraindication to neuraxial (spinal) anesthesia.
- History of chronic pain syndromes.
- Severe renal or hepatic dysfunction.
- Pregnancy or breastfeeding.
The study team makes the final eligibility decision.
Where it's taking place
- Erzurum, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Erzurum, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.